Literature DB >> 29118105

Neuropeptide S Activates Paraventricular Oxytocin Neurons to Induce Anxiolysis.

Thomas Grund1, Stephanie Goyon2, Yuting Li3, Marina Eliava4, Haikun Liu3, Alexandre Charlet2,5, Valery Grinevich4, Inga D Neumann6.   

Abstract

Neuropeptides, such as neuropeptide S (NPS) and oxytocin (OXT), represent potential options for the treatment of anxiety disorders due to their potent anxiolytic profile. In this study, we aimed to reveal the mechanisms underlying the behavioral action of NPS, and present a chain of evidence that the effects of NPS within the hypothalamic paraventricular nucleus (PVN) are mediated via actions on local OXT neurons in male Wistar rats. First, retrograde studies identified NPS fibers originating in the brainstem locus coeruleus, and projecting to the PVN. FACS identified prominent NPS receptor expression in PVN-OXT neurons. Using genetically encoded calcium indicators, we further demonstrated that NPS reliably induces a transient increase in intracellular Ca2+ concentration in a subpopulation of OXT neurons, an effect mediated by NPS receptor. In addition, intracerebroventricular (i.c.v.) NPS evoked a significant somatodendritic release of OXT within the PVN as assessed by microdialysis in combination with a highly sensitive radioimmunoassay. Finally, we could show that the anxiolytic effect of NPS seen after i.c.v. or intra-PVN infusion requires responsive OXT neurons of the PVN and locally released OXT. Thus, pharmacological blockade of OXT receptors as well as chemogenetic silencing of OXT neurons within the PVN prevented the effect of synthetic NPS. In conclusion, our results indicate a significant role of the OXT system in mediating the effects of NPS on anxiety, and fill an important gap in our understanding of brain neuropeptide interactions in the context of regulation of emotional behavior within the hypothalamus.SIGNIFICANCE STATEMENT Given the rising scientific interest in neuropeptide research in the context of emotional and stress-related behaviors, our findings demonstrate a novel intrahypothalamic mechanism involving paraventricular oxytocin neurons that express the neuropeptide S receptor. These neurons respond with transient Ca2+ increase and somatodendritic oxytocin release following neuropeptide S stimulation. Thereby, oxytocin neurons seem essential for neuropeptide S-induced anxiolysis, as this effect was blocked by pharmacological and chemogenetic inhibition of the oxytocin system.
Copyright © 2017 the authors 0270-6474/17/3712215-12$15.00/0.

Entities:  

Keywords:  DREADD; GCaMP6s; anxiety; microdialysis; neuropeptide S; oxytocin

Mesh:

Substances:

Year:  2017        PMID: 29118105      PMCID: PMC6596824          DOI: 10.1523/JNEUROSCI.2161-17.2017

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  68 in total

1.  Brain oxytocin: differential inhibition of neuroendocrine stress responses and anxiety-related behaviour in virgin, pregnant and lactating rats.

Authors:  I D Neumann; L Torner; A Wigger
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Intracellular calcium stores regulate activity-dependent neuropeptide release from dendrites.

Authors:  Mike Ludwig; Nancy Sabatier; Philip M Bull; Rainer Landgraf; Govindan Dayanithi; Gareth Leng
Journal:  Nature       Date:  2002-07-04       Impact factor: 49.962

Review 4.  The developmental origins of anxiety.

Authors:  Cornelius Gross; Rene Hen
Journal:  Nat Rev Neurosci       Date:  2004-07       Impact factor: 34.870

5.  Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Nancy Brandenburg; Michael Lane; Peter Roy-Byrne; Paul D Stang; Dan J Stein; Hans-Ulrich Wittchen
Journal:  Psychol Med       Date:  2005-07       Impact factor: 7.723

6.  Pharmacological characterization of human and murine neuropeptide s receptor variants.

Authors:  Rainer K Reinscheid; Yan-Ling Xu; Naoe Okamura; Joanne Zeng; Shinjae Chung; Rama Pai; Zhiwei Wang; Olivier Civelli
Journal:  J Pharmacol Exp Ther       Date:  2005-09-06       Impact factor: 4.030

7.  CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior.

Authors:  T L Bale; A M Davis; A P Auger; D M Dorsa; M M McCarthy
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

Review 8.  Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication.

Authors:  Rainer Landgraf; Inga D Neumann
Journal:  Front Neuroendocrinol       Date:  2004 Sep-Dec       Impact factor: 8.606

9.  Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats.

Authors:  Bernard Beck; Brigitte Fernette; Alain Stricker-Krongrad
Journal:  Biochem Biophys Res Commun       Date:  2005-07-08       Impact factor: 3.575

10.  Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects.

Authors:  Yan-Ling Xu; Rainer K Reinscheid; Salvador Huitron-Resendiz; Stewart D Clark; Zhiwei Wang; Steven H Lin; Fernando A Brucher; Joanne Zeng; Nga K Ly; Steven J Henriksen; Luis de Lecea; Olivier Civelli
Journal:  Neuron       Date:  2004-08-19       Impact factor: 17.173

View more
  9 in total

1.  Central neuropeptide-S administration alleviates stress-induced impairment of gastric motor functions through orexin-A.

Authors:  Mehmet Bülbül; Osman Sinen; Onur Bayramoğlu
Journal:  Turk J Gastroenterol       Date:  2020-01       Impact factor: 1.852

2.  Late aging alters behavioral sensitivity to ethanol in a sex-specific manner in Fischer 344 rats.

Authors:  Amy E Perkins; Andrew S Vore; Dennis Lovelock; Elena Varlinskaya; Terrence Deak
Journal:  Pharmacol Biochem Behav       Date:  2018-08-29       Impact factor: 3.533

Review 3.  Recent advances in mass spectrometry analysis of neuropeptides.

Authors:  Ashley Phetsanthad; Nhu Q Vu; Qing Yu; Amanda R Buchberger; Zhengwei Chen; Caitlin Keller; Lingjun Li
Journal:  Mass Spectrom Rev       Date:  2021-09-24       Impact factor: 9.011

Review 4.  Neuroimaging Predictors and Mechanisms of Treatment Response in Social Anxiety Disorder: an Overview of the Amygdala.

Authors:  Heide Klumpp; Jacklynn M Fitzgerald
Journal:  Curr Psychiatry Rep       Date:  2018-08-28       Impact factor: 8.081

5.  Sleep Deprivation Related Changes of Plasma Oxytocin in Males and Female Contraceptive Users Depend on Sex and Correlate Differentially With Anxiety and Pain Hypersensitivity.

Authors:  Sigrid Schuh-Hofer; Nicole Eichhorn; Valery Grinevich; Rolf-Detlef Treede
Journal:  Front Behav Neurosci       Date:  2018-08-02       Impact factor: 3.558

6.  Neuropeptide S Attenuates the Alarm Pheromone-Evoked Defensive and Risk Assessment Behaviors Through Activation of Cognate Receptor-Expressing Neurons in the Posterior Medial Amygdala.

Authors:  Yu-Feng Shao; Can Wang; Xiao-Ping Rao; Hua-Dong Wang; Yan-Li Ren; Jing Li; Chao-Yu Dong; Jun-Fan Xie; Xing-Wen Yang; Fu-Qiang Xu; Yi-Ping Hou
Journal:  Front Mol Neurosci       Date:  2021-12-24       Impact factor: 5.639

Review 7.  Can Neuropeptide S Be an Indicator for Assessing Anxiety in Psychiatric Disorders?

Authors:  Agnieszka Markiewicz-Gospodarek; Piotr Kuszta; Jacek Baj; Beata Dobrowolska; Renata Markiewicz
Journal:  Front Public Health       Date:  2022-04-26

Review 8.  A Role for Neuropeptide S in Alcohol and Cocaine Seeking.

Authors:  Nazzareno Cannella; Anna Maria Borruto; Michele Petrella; Maria Vittoria Micioni Di Bonaventura; Laura Soverchia; Carlo Cifani; Sara De Carlo; Esi Domi; Massimo Ubaldi
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-27

9.  Neuropeptide S Receptor Stimulation Excites Principal Neurons in Murine Basolateral Amygdala through a Calcium-Dependent Decrease in Membrane Potassium Conductance.

Authors:  Sion Park; Pia Flüthmann; Carla Wolany; Lena Goedecke; Hannah Maleen Spenner; Thomas Budde; Hans-Christian Pape; Kay Jüngling
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.